Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,545

Stocks News & Analysis

stocks

Ask the analyst: Where does GYG stand following its US exit?

All roads lead back home for Guzman Y Gomez.
stocks

Chart of the Week: The long term headwinds facing copper shares

The key factors challenging the bull case for copper demand.
stocks

Australia’s oldest REIT undervalued

This REIT remains undervalued as trophy properties shine through.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,930.909.200.10%
CAC 408,474.86137.571.65%
DAX 4025,580.88540.602.16%
Dow JONES (US)52,900.07594.831.14%
FTSE 10010,652.87174.531.67%
HKSE23,055.03174.010.76%
NASDAQ25,832.67207.36-0.80%
Nikkei 22568,733.151,741.81-2.47%
NZX 50 Index13,586.764.570.03%
S&P 5007,483.240.010.00%
S&P/ASX 2008,724.5013.900.16%
SSE Composite Index4,028.9083.54-2.03%

Market Movers